TNFAIP8 and acute myeloid leukemia: TNFAIP8 mRNA expression was correlated with ELN risk stratification, and our experimental validation further confirmed elevated TNFAIP8 levels in AML patients, particularly in relapsed cases, indicating its potential utility as both a diagnostic biomarker and therapeutic target.